<?xml version="1.0" encoding="UTF-8"?>
<p>A prospective study evaluated 17 renal transplant recipients. A loading dose of 100 mg for the first 3 days and then 20 mg per day was given. The result showed 15 patients (88%) responded to leflunomide with involved organ healing and viremia clearance.
 <sup>
  <xref rid="bibr113-1759720X20947296" ref-type="bibr">113</xref>
 </sup>
</p>
